MODULAÇAO DA SECREÇAO DO HORMONIO DE CRESCIMENTO PELA GHRELINA E OUTROS SECRETAGOGOS





MODULAÇAO DA SECREÇAO DO HORMONIO DE CRESCIMENTO PELA GHRELINA E OUTROS SECRETAGOGOS

(especial para SIIC © Derechos reservados)
Apresenta-se uma revisão sobre a ghrelina, os mecanismos de ação e possível papel fisiológico dos secretagogos de hormônio de crescimento e da ghrelina na secreção de hormônio de crescimento e os efeitos da administração endovenosa destes peptideos sobre a secreção de hormônio de crescimento no homem.
Autor:
Ana-maria J. Lengyel
Columnista Experto de SIIC

Institución:
Universidade Federal de São Paulo


Artículos publicados por Ana-maria J. Lengyel
Coautor
Larissa Bianca Paiva Cunha de Sá* 
Pós graduanda, Universidade Federal de São Paulo, São Paulo, Brasil*
Recepción del artículo
10 de Marzo, 2008
Aprobación
4 de Abril, 2008
Primera edición
15 de Abril, 2009
Segunda edición, ampliada y corregida
7 de Junio, 2021

Resumen
A secreção de hormônio de crescimento é modulada pelo hormônio liberador de hormônio de crescimento e pela somatostatina. Na ultima década foi descoberto um terceiro mecanismo de controle, envolvendo os secretagogos de hormônio de crescimento. A ghrelina é um peptídeo acilado, descoberto recentemente, que é produzido no estômago, porém também é sintetizado no hipotálamo. Este peptídeo é capaz de liberar hormônio de crescimento, além de aumentar a ingesta alimentar. A ghrelina endógena parece amplificar o padrão básico de secreção de hormônio de crescimento, ampliando a resposta do somatotrófo ao hormônio liberador de hormônio de crescimento. Este peptídeo estimula multiplas vias intracelulares interdependentes no somatotrófo, envolvendo a proteina quinase C, proteina quinase A, e sistemas moduladores de cálcio extracelular. Entretanto, como a liberação de GH induzida pela ghrelina in vivo é mais acentuada que in vitro, seu local de atuação predominante é no hipotálamo. No presente trabalho apresentamos uma revisão sobre a descoberta da ghrelina, os dados existentes sobre os mecanismos de ação e possível papel fisiológico dos secretagogos de hormônio de crescimento e da ghrelina na secreção de hormônio de crescimento e, finalmente, os efeitos da administração endovenosa destes peptideos sobre a secreção de hormônio de crescimento no homem.

Palabras clave
ghrelina, GH, secretagogos do hormônio de crescimento, GHS


Artículo completo

(castellano)
Extensión:  +/-6.61 páginas impresas en papel A4
Exclusivo para suscriptores/assinantes

Abstract
Growth hormone-releasing hormone and somatostatin modulate growth hormone secretion. A third mechanism has been discovered in the last decade, involving the action of growth hormone secretagogues . Ghrelin is a new acylated peptide mainly produced by the stomach, but also synthesized in the hypothalamus. This compound increases both growth hormone release and food intake. The relative roles of hypothalamic and circulating ghrelin on growth hormone secretion are still unknown. Endogenous ghrelin might amplify the basic pattern of growth hormone secretion, optimizing somatotroph responsiveness to growth hormone-releasing hormone. This peptide activates multiple interdependent intracellular pathways at the somatotroph, involving protein kinase C, protein kinase A and extracellular calcium systems. However, as ghrelin induces a greater release of growth hormone in vivo, its main site of action is the hypothalamus. In the current paper we review the available data on the discovery of this peptide, the mechanisms of action and possible physiological roles of growth hormone secretagogues and ghrelin on growth hormone secretion, and, finally, the regulation of growth hormone release in man after intravenous administration of these peptides.

Key words
ghrelin, growth hormone secretagogues


Clasificación en siicsalud
Artículos originales > Expertos de Iberoamérica >
página   www.siicsalud.com/des/expertocompleto.php/

Especialidades
Principal: Endocrinología y Metabolismo
Relacionadas: Bioquímica, Diagnóstico por Laboratorio, Medicina Interna, Pediatría



Comprar este artículo
Extensión: 6.61 páginas impresas en papel A4

file05.gif (1491 bytes) Artículos seleccionados para su compra



Enviar correspondencia a:
Ana-Maria J. Lengyel, Universidade Federal de São Paulo Escola Paulista de Medicina, 04039-002, Rua Pedro de Toledo, 910, São Paulo, Brasil
Bibliografía del artículo
1. Bowers CY, Momany FA, Reynolds GA e col. On the in vitro and in vivo activity of a new synthetic hexapeptide that acts on the pituitary to specifically release growth hormone. Endocrinology 114:1537-1545, 1984.
2. Smith RG, Van der Ploeg LHT, Howard AD e col. Peptidomimetic regulation of growth hormone secretion. Endocr Rev 18:621-645, 1997.
3. Korbonits M, Grossman A. Growth hormone-releasing peptide and its analogues -novel stimuli to growth hormone release. Trends Endocrinol Metab 6:43-49, 1995.
4. Howard AD, Feighner SD, Cully DF e col. A receptor in pituitary and hypothalamus that functions in growth hormone release. Science 273:947-977, 1996.
5. Kojima M, Hosoda H, Date Y e col. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656-660, 1999.
6. Arvat E, DiVito L, Broglio F e col. Preliminary evidence that ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. J Endocrinol Invest 23:493-495, 2000.
7. Korbonits M, Goldstone A P, Gueorguiev M e col. Ghrelin- a hormone with multiple functions. Front Neuroendocrinol 25:27-68, 2004.
8. Van der Lely AJ, Tschop M, Heiman ML e col. Biological, physiological, pathophysiological, and pharmacological aspects of ghrelin. Endocr Rev 25:426-457, 2004.
9. Sun Y, Wang P, Zheng H e col. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101:4679-4684, 2004.
10. Gnanapavan S, Kola B, Bustin SA e col. The tissue distribution of the mRNA of ghrelin and subtypes of its receptor, GHS-R, in humans. J Clin Endocrinol Metab 87:2988- 2991, 2002.
11. Cummings DE, Weigle DS, Frayo RS e col. Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery. N Engl J Med 346:1623-1630, 2002.
12. Banks WA, Tschop M, Robinson SM e col. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 302:822-827, 2002.
13. Takaya K, Ariyasu H, Kanamoto N e col. Ghrelin strongly stimulates growth hormone release in humans. J Clin Endocrinol Metab 85:4908-4911, 2000.
14. Arvat E, Maccario M, DiVito L e col. Endocrine activities of ghrelin, a natural growth hormone secretagogue (GHS), in humans: comparison and interactions with hexarelin, a nonnatural peptidyl GHS, and GH-releasing hormone. J Clin Endocrinol Metab 86:1169-1174, 2001.
15. Peñalva A, Carballo A, Pombo M e col. Effect of growth hormone (GH)-releasing hormone (GHRH), atropine, pyridostigmine, or hypoglycemia on GHRP-6-induced GH secretion in man. J Clin Endocrinol Metab 76:168-171, 1993.
16. Hataya Y, Akamizu T, Takaya K e col. A low dose of ghrelin stimulates growth hormone (GH) release synergistically with GH-releasing hormone in humans. J Clin Endocrinol Metab 86:4552-4555, 2001.
17. Popovic V, Damjanovic S, Micic D e col. Blocked growth hormone-releasing peptide (GHRP-6)-induced GH secretion and absence of the synergic action of GHRP-6 plus GH-releasing hormone in patients with hypothalamopituitary disconnection: evidence that GHRP-6 main action is exerted at the hypothalamic level. J Clin Endocrinol Metab 80:942-947, 1995.
18. Popovic V, Miljic D, Micic D e col. Ghrelin main action on the regulation of growth hormone release is exerted at hypothalamic level. J Clin Endocrinol Metab 88:3450-3453, 2003.
19. Tannenbaum GS, Bowers CY. Interactions of growth hormone secretagogues and growth hormone-releasing hormone/ somatostatin. Endocrine 14:21-27, 2001.
20. Pandya N, Mott-Friberg R, Bowers CY e col. Growth hormone (GH)-releasing peptide-6 requires endogenous hypothalamic GH-releasing hormone for maximal GH stimulation. J Clin Endocrinol Metab 83:1186-1189, 1988.
21. Dickson SL, Doutrelant -Viltart O, Leng G. GH-deficient dw/dw rats and lit/lit mice show increased Fos expression in the hypothalamic arcuate nucleus following systemic injection of GH-releasing peptide-6. J Endocrinol 146:519-526, 1995.
22. Maheshwari H, Rahim A, Shalet SM e col. Selective lack of growth hormone (GH) response to the GH-releasing peptide hexarelin in patients with GH-releasing hormone receptor deficiency. J Clin Endocrinol Metab 84:956-959, 1999.
23. Wren AM, Small CJ, Fribbens CV e col. The hypothalamic mechanisms of the hypophysiotropic action of ghrelin. Neuroendocrinology 76:316-324, 2002.
24. Korbonits M, Little JA, Forsling ML e col. The effect of growth hormone secretagogues and neuropeptide Y on hypothalamic hormone release from acute rat hypothalamic explants. J Neuroendocrinol 11:521-528, 1999.
25. Guillaume V, Magnan E, Cataldi M e col. Growth hormone (GH)-releasing hormone secretion is stimulated by a new GH-releasing hexapeptide in sheep. Endocrinology 135:1073-1076, 1994.
26. Goth MI, Lyons CE, Canny BJ e col. Pituitary adenylate cyclase activacting polypeptide, growth hormone (GH)-releasing peptide and GH-releasing hormone stimulate GH release through distinct pituitary receptors. Endocrinology 130:939-944, 1992.
27. Malagon MM, Luque RM, Ruiz-Guerrero E e col. Intracellular signaling mechanisms mediating ghrelin-stimulated growth hormone release in somatotropes. Endocrinology 144:5372-5380, 2003.
28. Kineman RD, Luque RM. Evidence that ghrelin is as potent as growth hormone (GH)- realising hormone (GHRH) in realising GH from primary pituitary cell cultures of a nonhuman primate (Papio anubis), acting through intracellular signaling pathways distinct from GHRH. Endocrinology 148:4440-4449, 2007.
29.Tolle V, Bassant MH, Zizzari P e col. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology 143:1353-1361, 2002.
30. Okimura Y, Ukai K, Hosoda H e col. The role of circulating ghrelin in growth hormone (GH) secretion in freely moving male rats. Life Sci 72:2517-2524, 2003.
31. Tannenbaum GS, Epelbaum J, Bowers CY. Interrelationship between the novel peptide ghrelin and somatostatin/growth hormone-releasing hormone in regulation of pulsatile growth hormone secretion. Endocrinology 144:967-974, 2003.
32. Barkan AL, Dimaraki EV, Jessup SK e col. Ghrelin secretion in humans is sexually dimorphic, suppressed by somatostatin, and not affected by the ambient growth hormone levels. J Clin Endocrinol Metab 88:2180-2184, 2003.
33. Halem HA, Taylor JE, Dong JZ ecol. Novel analogs of ghrelin: physiological and clinical implications. Eur J Endocrinol 151(Suppl.1):S71-S75, 2004.
34. Zizzari P, Halem H,Taylor J e col. Endogenous ghrelin regulates episodic growth hormone (GH) secretion by amplifying GH pulse amplitude: evidence from antagonism of the GH secretagogue-R1a receptor. Endocrinology 146:3836-3842, 2005.
35. Tannenbaum GS, Samia M, Chen Q e col. Antagonism of the growth hormone secretagogue receptor unmasks a role for ghrelin in maintaining high GH pulse amplitude under physiological conditions. Endo Soc 87th Ann Meet San Diego,USA, June 4-7, 2005.
36. Pantel J, Legendre M, Cabrol S et col. Loss of constitutive activity of the growth hormone secretagogue receptor in familial short stature. J Clin Invest 116:760-768, 2006.
37. Koutkia P, Canavan B, Breu J e col. Nocturnal ghrelin pulsatility and response to growth hormone secretagogues in healthy men . Am J Physiol Endocrinol Metab 287:E506-E512, 2004.
38. Kamegai J, Tamura H, Shimizu T e col. The role of pituitary ghrelin in growth hormone (GH) secretion: GH-releasing hormone-dependent regulation of pituitary ghrelin gene expression and peptide content. Endocrinology 145:3731-3738, 2004.
39. Sun Y, Ahmed S, Smith RG .Deletion of ghrelin impairs neither growth nor appetite. Mol Cell Biol 23:7973-7981, 2003.
40. Shuto Y, Shibasaki T, Otagiri A e col. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 109:1429-1436, 2002.
41. Sun Y, Wang P, Zheng H e col. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 101:4679-4684, 2004.
42. Peino R, Baldelli R, Rodriguez-Garcia J e col. Ghrelin-induced growth hormone secretion in humans. Eur J Endocrinol 143:R11-R14, 2000.
43. Broglio F, Benso A, Castiglioni C e col. The endocrine response to ghrelin as a function of gender in humans in young and elderly subjects. J Clin Endocrinol Metab 88:1537-1542, 2003.
44. Cordido F, Penalva A, Dieguez C e col. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. J Clin Endocrinol Metab 76:819-823, 1993.
45. Tassone F, Broglio F, Destefanis S e col. Neuroendocrine and metabolic effects of acute ghrelin administration in human obesity. J Clin Endocrinol Metab 88:5478-5483, 2003.
46. Maccario M, Arvat E, Procopio M e col. Metabolic modulation of the growth hormone-releasing activity of hexarelin in man. Metabolism 44:134-138, 1995.
47. Di Vito L, Broglio F, Benso A e col. The GH-releasing effect of ghrelin, a natural GH secretagogue, is only blunted by the infusion of exogenous somatostatin in humans. Clin Endocrinol 56:643-648, 2002.
48. Broglio F, Benso A, Gottero C e col. Effects of glucose, free fatty acids or arginine load on the GH-releasing activity of ghrelin in humans. Clin Endocrinol 57:265-271, 2002.
49. Maier C, Schaller G, Buranyi B e col. The cholinergic system controls ghrelin release and ghrelin-induced growth hormone release in humans. J Clin Endocrinol Metab 89:4729-4733, 2004.
50. Gertz BJ, Sciberras DG, Yogendran L e col. L-692,429, a nonpeptide growth hormone (GH) secretagogue, reverses glucocorticoid suppression of GH secretion. J Clin Endocrinol Metab 79:745-749, 1994.
51. Arvat E, DiVito L, Gianotti L e col. Mechanisms undelying the negative growth hormone (GH) autofeedback on the GH-releasing effect of hexarelin in man. Metabolism 46:83-88, 1997.
52. Leal-Cerro A, Pumar A, Garcia-Garcia E e col. Inhibition of growth hormone release after the combined administration of GHRH and GHRP-6 in patients with Cushing's syndrome. Clin Endocrinol 41:649-654, 1994.
53. Borges MH, DiNinno FB, Lengyel AM. Different effects of growth hormone releasing peptide (GHRP-6) and GH-releasing hormone on GH release in endogenous and exogenous hypercortisolism. Clin Endocrinol 46:713-718, 1997.
54. Leal-Cerro A, Torres E, Soto A e col. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses. Neuroendocrinology 76:390-396, 2002.
55. Correa-Silva SR, Nascif SO, Lengyel AMJ. Decreased GH secretion and enhanced ACTH and cortisol release after ghrelin administration in Cushing's disease: comparison with GH- releasing peptide -6 (GHRP-6) and GHRH. Pituitary 9:101-107, 2006.
56. Arvat E, Giordano R, Ramunni J e col. Adrenocorticotropin and cortisol hyperresponsiveness to hexarelin in patients with Cushing's disease bearing a pituitary microadenoma, but not in those with macroadenoma. J Clin Endocrinol Metab 83:4207-4211, 1998.
57. Pinto AC, Silva MR, Martins MR e col. Effects of short-term glucocorticoid deprivation on growth hormone (GH) response to GH-releasing peptide-6: studies in normal men and in patients with adrenal insufficiency. J Clin Endocrinol Metab 85:1540-1544, 2000.
58. Ramos-Dias JC, Pimentel-Filho F, Reis A F e col. Different growth hormone (GH) response to GH-releasing peptide and GH-releasing hormone in hyperthyroidism .J Clin Endocrinol Metab 81:1343-1346, 1996.
59. Nascif SO, Correa-Silva SR, Silva MR e col. Decreased ghrelin- induced GH release in thyrotoxicosis: comparison with GH- realising peptide-6 (GHRP-6) and GHRH. Pituitary 10:27-33, 2007.
60. Lengyel AMJ. From growth hormome- realising peptides to ghrelin: discovery of new modulators of GH secretion. Arq Bras Endocrinol Metab 50:17-24, 2006.
61. Weffort RFVB, Ramos-Dias JC, Chipoch C e col. Growth hormone (GH) response to GH-releasing peptide-6 in patients with insulin-dependent diabetes mellitus. Metabolism 46:706-710, 1997.
62. Broglio F, Gianotti L, Destefanis S e col. The endocrine response to acute ghrelin administration is blunted in patients with anorexia nervosa, a ghrelin hypersecretory state. Clin Endocrinol 60:592-599, 2004.

 
 
 
 
 
 
 
 
 
 
 
 
Está expresamente prohibida la redistribución y la redifusión de todo o parte de los contenidos de la Sociedad Iberoamericana de Información Científica (SIIC) S.A. sin previo y expreso consentimiento de SIIC.
ua31618